Healthcare
Technology
People

Healthcare
Technology
People

Portfolio
People
News
Stories & Ideas
About
Fintech Index
FBRI
Jobs

Search for:

Find a portfolio company, person, community initiative, or story

News

Category

Enterprise IT
Health IT/Services
MedTech
Other
Therapeutics

GlobeNewswire

Ultragenyx Announces Positive Longer-term Results from First Three Cohorts of Phase 1/2 Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency
May 13, 2020
PR Newswire

TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
May 13, 2020
GlobeNewswire

SPEAR T-cells Derived from Stem-Cells Kill Cancer Targets – Adaptimmune Presents Advances from its Allogeneic Platform at ASGCT Annual Meeting
May 12, 2020
GlobeNewswire

Arvelle Therapeutics: SK Life Science, Inc. Announces US Availability of XCOPRI® (cenobamate tablets) for the Treatment of Partial (Focal) Onset Seizures in Adults with Epilepsy
May 12, 2020
FierceBiotech

Next-gen biotech Caribou Biosciences nabs Array (now Pfizer) cancer R&D exec as clinical lead
May 12, 2020
PR Newswire

Shift Technology and Snapsheet Partner to Add Fraud Detection to Snapsheet Claims Management Platform
May 11, 2020
GlobeNewswire

Tempest Therapeutics Announces First Patient Dosed in TPST-1495 Clinical Study: Dual EP2/4 Antagonist Targeting Solid Tumors
May 7, 2020
PR Newswire

FARAPULSE’s Pioneering Clinical Results Link Compelling Long-term Outcomes to Established Safety and Lesion Durability Data
May 7, 2020
TechCrunch

Owkin raises $25 million as it builds a secure network for healthcare analysis and research
May 7, 2020
Forbes

Tradier Teams With Q.ai, A Forbes Company, To Bring AI And Big Data Analytics To Customers And Retail Investors
May 7, 2020
PR Newswire

Caribou Biosciences and MaxCyte Enter into Clinical and Commercial License Agreement
May 7, 2020
PR Newswire

Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
May 6, 2020
Business Wire

OCC Selects Axoni to Modernize Securities Lending Infrastructure
May 5, 2020
GlobeNewswire

Snapsheet Brings Claims Management Platform to Clearcover
May 5, 2020
GlobeNewswire

GeneTx and Ultragenyx Announce GTX-102 Granted Fast Track Designation by U.S. FDA for Treatment of Angelman Syndrome
May 4, 2020
Business Wire

SonderMind hires Douglas Newton, MD, MPH as Chief Medical Officer
May 4, 2020
PR Newswire

Whatfix Named a Finalist for Business Intelligence Group’s 2020 Excellence in Customer Service Award
April 30, 2020
EurekAlert

Frost & Sullivan recognizes Insilico as innovation leader in drug discovery
April 30, 2020
PR Newswire

Pharmaceutical Manufacturers and Wholesalers Continue to Choose TraceLink As Industry Readies for DSCSA Saleable Returns Verification Requirement
April 29, 2020
GlobeNewswire

Apellis Reports Analysis from Phase 1b Geographic Atrophy Study
April 28, 2020
Business Wire

Avalyn Pharma Secures $35.5 Million Series B Financing, Broadens Development Portfolio
April 27, 2020
PR Newswire

Innovent Announces First Patient Dosed in a Pivotal Trial of Parsaclisib in Patients with Indolent Lymphoma in China
April 27, 2020
PR Newswire

Novaerus Defend 1050 Proven to Reduce Coronavirus Surrogate by 99.99%
April 27, 2020
Business Wire

Xilio Therapeutics Appoints Martin H. Huber, M.D. as Chief Medical Officer
April 27, 2020
PR Newswire

Applied BioMath, LLC Announces Collaboration with Xilio Therapeutics
April 27, 2020
Business Wire

Vertex Pharmaceuticals and Affinia Therapeutics Establish Multi-Year Collaboration to Discover and Develop Novel AAV Capsids for Genetic Therapies
April 27, 2020
GlobeNewswire

Orchard Therapeutics Announces First Patient Dosed with OTL-201 Gene Therapy in Proof-of-Concept Clinical Trial for Sanfilippo Syndrome (MPS-IIIA)
April 27, 2020
PR Newswire

Insilico Medicine enters into a collaboration research with Astellas Pharma Inc. to apply novel generative artificial intelligence system for a conventionally challenging target family
April 27, 2020
GlobeNewswire

Hua Medicine Announces Positive Results of the Combination Study of Dorzagliatin with Empagliflozin (a SGLT-2 inhibitor)
April 26, 2020
PR Newswire

Innovent and Eli Lilly Announce NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum as First-Line Therapy in Non-squamous NSCLC
April 23, 2020
GlobeNewswire

Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Antibody SRF388
April 23, 2020
GlobeNewswire

Flywire Unveils Framework to Help Universities Increase Fall 2020 Enrollment
April 23, 2020
PR Newswire

Innovent Biologics Announces FDA Approval of Pemazyre™ (Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma
April 20, 2020
PR Newswire

TraceLink Announces $1 Million Charitable Funding for COVID-19 Relief, Issues Call for Grant Proposals
April 16, 2020
GlobeNewswire

Precision Biosciences Appoints Dora Alvarado as Senior Vice President of Human Resources
April 15, 2020
FierceBiotech

Boehringer Ingelheim taps Insilico Medicine for AI drug target collaboration
April 14, 2020
PR Newswire

Centivo Launches New Health Plan Solution
April 9, 2020
GlobeNewswire

Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR20A for Relapsed/Refractory NHL, CLL, and SLL
April 7, 2020
Business Wire

Beam Therapeutics Licenses SIRION Biotech’s LentiBOOST™ Technology for its CAR-T pipeline
April 7, 2020
Business Wire

SonderMind Raises $27 Million to Expand its Accessible Behavioral Health Platform
April 6, 2020
FierceBiotech

Compass Therapeutics’ immuno-oncology prospect clears solid tumors in mice
April 3, 2020
PR Newswire

Blueprint Medicines Announces the Achievement of Key Portfolio Milestones
April 1, 2020
GlobeNewswire

Orchard Therapeutics Outlines Business Impact of COVID-19
March 31, 2020
GlobeNewswire

REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder
March 31, 2020
GlobeNewswire

Affinia Therapeutics Raises $60M in Series A Financing to Advance Rational Design AAV Platform and Transformative Gene Therapies
March 31, 2020
GlobeNewswire

Arvelle Announces European Medicines Agency Acceptance of the Marketing Authorization Application (MAA) for Cenobamate
March 30, 2020
Business Wire

Compass Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy and Safety of CTX-471, a Unique Fully Human Agonist of CD137
March 30, 2020
GlobeNewswire

Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China
March 25, 2020
PR Newswire

AI-Derived COVID-19 Experimental Data and Reagent Insights Now Available From BenchSci to Accelerate R&D Efforts
March 24, 2020
GlobeNewswire

Menlo Therapeutics Appoints Andrew Saik as Chief Financial Officer
March 24, 2020
GlobeNewswire

Orchard Therapeutics Appoints Company Founder and Gene Therapy Pioneer Bobby Gaspar, M.D., Ph.D., as New Chief Executive Officer
March 18, 2020
GlobeNewswire

Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Candidate SRF617
March 17, 2020
PR Newswire

Beijing Tide Pharmaceutical and Insilico Medicine enter into a strategic partnership agreement for cancer therapy
March 17, 2020
GlobeNewswire

Hua Medicine Announces 2019 Annual Results
March 16, 2020
GlobeNewswire

GeneTx and Ultragenyx Announce First Patient Dosed in Phase 1/2 Clinical Trial of GTX-102 in Patients with Angelman Syndrome
March 16, 2020
PR Newswire

Blueprint Medicines Announces Part 1 Results from PIONEER Trial Showing Broad Activity of Avapritinib Across Measures of Mast Cell Burden, Clinical Outcomes and Quality of Life in Indolent Systemic Mastocytosis
March 16, 2020
PR Newswire

Buoy Health Calms Coronavirus Fear, Serves Up Population Health Data to Help Control the Rising Epidemic in the United States
March 16, 2020
GlobeNewswire

Beam Therapeutics Announces Key R&D Appointments
March 16, 2020
GlobeNewswire

Acacia Pharma Announces Brief Extension of FDA Review Period for NDA for BYFAVO™, an Ultra-short Acting and Reversible Anesthetic for Procedural Sedation
March 12, 2020
GlobeNewswire

Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano
March 11, 2020
PR Newswire

TraceLink Achieves ISO 27017:2015 Security Certification
March 11, 2020
PR Newswire

TraceLink’s Continued Momentum Fuels Strong Company Growth and Investments in Q4 2019
March 10, 2020
Business Wire

Devoted Health recognized by Forbes as one of America’s Best Startup Employers in 2020
March 10, 2020
PR Newswire

Protenus Named One of Forbes’ Best Startup Employers of 2020
March 10, 2020
FierceBiotech

FierceMedTech names Insilico Medicine as one of its ‘Fierce 15’ companies of 2019
March 9, 2020
PR Newswire

Menlo Therapeutics and Foamix Pharmaceuticals Complete Merger, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications
March 9, 2020
PR Newswire

PatientPing Launches Educational Website Dedicated to CMS’s Interoperability and Patient Access Rule
March 9, 2020
GlobeNewswire

SIGA Announces Collaboration with Turnstone Biologics
March 3, 2020
PR Newswire

TraceLink Launches Global Corporate Social Responsibility Program, Focusing on Community Service and Philanthropic Contributions to Healthcare and STEM Organizations
March 3, 2020
Business Wire

IAA and Snapsheet Announce Partnership to Automate the Total Loss Process and Reduce Claims Cycle Time
March 3, 2020
PR Newswire

Innovent Biologics Announces First Patient Dosed in the Pivotal Registrational Trial of Pemigatinib in Patients with Advanced Cholangiocarcinoma in China
March 3, 2020
Newswire

Artemis Health and Quantros Partner to Provide a Holistic View of Healthcare Provider Quality
March 2, 2020
GlobeNewswire

Acacia Pharma Announces Changes to its Officers and Board of Directors
March 2, 2020
FierceBiotech

Akrevia no more, Xilio Therapeutics bags $101M for I-O programs
March 2, 2020
GlobeNewswire

TradeBlock and Grayscale Investments Partner to Publish TradeBlock Grayscale Digital Large Cap Index (DLCX)
February 27, 2020
FierceBiotech

Insilico Medicine taps GSK alum for a 6-month AI sprint aimed at brain cancer
February 27, 2020
GlobeNewswire

Ultragenyx and Kyowa Kirin Announce FDA Acceptance and Priority Review Designation of Supplemental Biologics License Application for Crysvita® (burosumab) for Tumor-Induced Osteomalacia (TIO)
February 27, 2020
PR Newswire

Novaerus Donates Air Dis-infection Technology to Wuhan
February 27, 2020
GlobeNewswire

Acacia Pharma Announces US FDA Approval of BARHEMSYS® (amisulpride) for the Treatment and Prevention of Postoperative Nausea and Vomiting (PONV)
February 27, 2020
Business Wire

Threat Stack Wins Cloud Security Category in Annual InfoSec Awards at RSA Conference 2020
February 25, 2020
Business Wire

Wellframe Announces Collaboration with Blue Cross and Blue Shield of Kansas City to Deliver Digital Health Management Solution to Members
February 24, 2020
Business Wire

Caribou Biosciences and ProMab Biotechnologies Announce Sale and Assignment Agreement for Humanized scFv Targeting BCMA
February 19, 2020
GlobeNewswire

Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
February 18, 2020
PR Newswire

Breached Patient Records Tripled in 2019 as Malicious Actors Create New Problems for Patients
February 18, 2020
Business Wire

Nebula Genomics, Partnering with BGI, Sets Industry Standard by Offering 30x Whole-Genome Sequencing for $299
February 18, 2020
TechCrunch

Boston’s year jump starts as two local startups raise $520M in two rounds
February 17, 2020
GlobeNewswire

Hua Medicine appoints Dr. Fuxing Tang, a former U.S. FDA Officer, as Chief Technology Officer
February 13, 2020
Bloomberg

Flywire Becomes a Unicorn With New Investment From Goldman
February 13, 2020
PR Newswire

Avidity Biosciences Appoints Joseph Baroldi as Chief Operating Officer
February 12, 2020
Business Wire

Atrius Health Engages Kyruus to Advance Novel Digital Patient Access Initiatives
February 12, 2020

page 1 1
page 2 2
page 3 3
page 4 4
page 5 5
page 6 6
page 7 7
page 8 8
page 9 9
page 10 10
page 11 11
page 12 12
page 13 13
page 14 14
page 15 15
page 16 16
page 17 17
page 18 18
page 19 19
page 20 20
page 21 21
page 22 22

We create and invest in healthcare and technology companies that improve lives all over the world.

Get the latest updates

Healthcare Technology

We respect your privacy.

Get the latest updates

Healthcare Technology

We respect your privacy.

Leave this field empty if you're human:

Jump to —

Portfolio
People
News
Stories & Ideas
About
Fintech Index
FBRI
Jobs

Cambridge
1 Main St.
13th Floor
Cambridge, MA 02142
London
33 Foley Street
London, W1W 7TL
San Francisco
140 New Montgomery Street
2nd Floor, Suite A
San Francisco, CA 94105

© 2023
Terms of Use
Privacy Policy
Stay in Touch

The information on these pages is intended solely for the benefit of entrepreneurs seeking venture capital investments. F-Prime is not offering investment advisory services nor is it offering to sell securities. F‑Prime provides advisory services as Impresa Management LLC. The list of portfolio companies includes investments made by Fidelity Ventures and Eight Roads. FBRI is an affiliate of F‑Prime and a subsidiary of FMR LLC.